Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Abstract Background Little is known about the nature of metastasis to small cervical lymph nodes (SCLNs) in the patients with nasopharyngeal carcinoma (NPC) examined by using 18-fluoro-2-deoxy-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). The present study aimed to eva...

Full description

Bibliographic Details
Main Authors:	Hao Peng, Lei Chen, Ling-Long Tang, Wen-Fei Li, Yan-Ping Mao, Rui Guo, Yuan Zhang, Li-Zhi Liu, Li Tian, Xu Zhang, Xiao-Ping Lin, Ying Guo, Ying Sun, Jun Ma
Format:	Article
Language:	English
Published:	BMC 2017-12-01
Series:	Chinese Journal of Cancer
Subjects:	Nasopharyngeal carcinoma 18-fluoro-2-deoxy-glucose positron emission tomography with computed tomography (18F-PET/CT) Magnetic resonance image Intensity-modulated radiotherapy Small cervical lymph nodes
Online Access:	http://link.springer.com/article/10.1186/s40880-017-0265-9

Similar Items

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
by: Sébastien Thureau, et al.
Published: (2018-10-01)

Appropriateness criteria of FDG PET/CT in oncology
by: Archi Agrawal, et al.
Published: (2015-04-01)

18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma
by: Jie Xu, et al.
Published: (2019-07-01)

PET Imaging in Bladder Cancer: An Update and Future Direction
by: Jules Zhang-Yin, et al.
Published: (2023-04-01)

Volumetric parameters on 18F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET
by: Guobing Liu, et al.
Published: (2019-08-01)

Brain metastases assessment by FDG-PET/CT: can it eliminate the necessity for dedicated brain imaging?
by: Mamdouh A. Zidan, et al.
Published: (2020-11-01)

Reflecting on the utility of standardized uptake values on 18F-FDG PET in nasopharyngeal carcinoma
by: Xiufang Qiu, et al.
Published: (2022-05-01)

Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging
by: Fu-Li Wang, et al.
Published: (2016-01-01)

Mathematical Models for FDG Kinetics in Cancer: A Review
by: Sara Sommariva, et al.
Published: (2021-08-01)

A novel PET tracer 18F-deoxy-thiamine: synthesis, metabolic kinetics, and evaluation on cerebral thiamine metabolism status
by: Changpeng Wang, et al.
Published: (2020-10-01)

PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma
by: Ashraf Anas Zytoon, et al.
Published: (2020-10-01)

Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer
by: Gaofeng Sun, et al.
Published: (2019-03-01)

Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient
by: Christos Sachpekidis, et al.
Published: (2017-12-01)

Predictive value of Dmax and %ΔSUVmax of 18F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma
by: Jun Dang, et al.
Published: (2023-10-01)

The Contribution of [18]F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography to the diagnosis and staging of signet-ring cell carcinoma of the stomach
by: Selda Yilmaz Tatar, et al.
Published: (2021-01-01)

Selectively recommend 18F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas
by: Chuanben Chen, et al.
Published: (2021-11-01)

Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer's Disease-related Biomarker in 5XFAD Mice
by: Nai-An Xiao, et al.
Published: (2015-01-01)

Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT
by: Ari Chong, et al.
Published: (2017-03-01)

Unexpected -[18F] fluoro-2-deoxy-D-glucose accumulation in subarachnoid hemorrhage due to an aneurysm rupture
by: Hiroyuki Tokue, MD, et al.
Published: (2021-03-01)

Paclitaxel-induced dermal hypersensitivity lesions: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography
by: Inci Uslu Biner, et al.
Published: (2018-01-01)

The Correlation between CT Characteristics of Non-small Lung Cancer and the Performance of 18F-FDG PET and the Expression of Glut1 Protein
by: Xin WANG, et al.
Published: (2009-07-01)

Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer
by: Po-Jui Chen, et al.
Published: (2020-06-01)

Comparison of cardiac image-derived input functions for quantitative whole body [18F]FDG imaging with arterial blood sampling
by: Murray Bruce Reed, et al.
Published: (2023-03-01)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
by: U. Plöckinger, et al.
Published: (2018-03-01)

Intratumoral 18F-FLT infusion in metabolic targeted radiotherapy
by: Thititip Tippayamontri, et al.
Published: (2019-04-01)

Frequency and Clinical Significance of Incidental Prostatic FDG uptake in FDG PET imaging
by: Elif Özdemir, et al.
Published: (2020-06-01)

Model Corrected Blood Input Function to Compute Cerebral FDG Uptake Rates From Dynamic Total-Body PET Images of Rats in vivo
by: James C. Massey, et al.
Published: (2021-04-01)

Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer’s disease
by: Camila de Godoi Carneiro, et al.
Published: (2022-08-01)

Atypical Uptake of 18<sup>F</sup>DG in White Adipose Tissue During PET/CT in Children
by: M. M. Dunaikin, et al.
Published: (2023-08-01)

Early Response Monitoring Following Radiation Therapy by Using [18F]FDG and [11C]Acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration
by: Yi-Hsiu Chung, et al.
Published: (2017-11-01)

Characterization of a novel model for atherosclerosis imaging: the apolipoprotein E-deficient rat
by: Jürgen W. A. Sijbesma, et al.
Published: (2023-12-01)

Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors
by: Yukiko Nishikawa, et al.
Published: (2017-09-01)

Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder
by: F. Montes de Jesus, et al.
Published: (2021-03-01)

Effect of IDH3a on glucose uptake in lung adenocarcinoma: A pilot study based on [18F]FDG
by: Bulin Du, et al.
Published: (2019-09-01)

Advances in the application of 18F-FDG PET/CT radiomics for diagnosis, treatment and prognosis prediction of lymphoma
by: CHENG Ran, et al.
Published: (2023-06-01)

PET/CT in Multiple Myeloma: Beyond FDG
by: Federica Matteucci, et al.
Published: (2021-01-01)

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [<sup>18</sup>F]FDG PET/CT
by: Filipe Montes de Jesus, et al.
Published: (2021-01-01)

[18F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis
by: Laure Sarda-Mantel, et al.
Published: (2021-08-01)

Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography
by: Sawada S, et al.
Published: (2016-04-01)

2-[<sup>18</sup> F]fluoro-2-deoxy-<smcaps>d</smcaps>-glucose (FDG) positron-emission tomography (PET) findings of chronic expanding intrapericardial hematoma: a potential interpretive pitfall that mimics a malignant tumor
by: Tokue Hiroyuki, et al.
Published: (2013-01-01)